Currents in Pharmacy Teaching and Learning
Volume 2, Issue 3 , Pages 138-143 , July 2010

A student practice experience focusing on the intellectually disabled

  • Nancy Brahm, PharmD, MS

      Affiliations

    • Corresponding Author InformationCorresponding author: Nancy Brahm, PharmD, MS, Clinical Associate Professor, University of Oklahoma College of Pharmacy, 4502 E. 41st Street, 2H17, Tulsa, OK, 74135-2512
    • ,
  • Kevin C. Farmer, PhD

References 

  1. Rush KS, Bowman LG, Eidman SL, Toole LM, Mortenson BP. Assessing psychopathology in individuals with developmental disabilities. Behav Modif. 2004;28:621–637
  2. Cates ME, Monk-Tutor MR, Drummond SO. Mental health and psychiatric pharmacy instruction in US colleges and schools of pharmacy. Am J Pharm Educ. 2007;71:Article 4
  3. American Association of Colleges of Pharmacy. Academic Pharmacy's Vital Statistics. http://www.aacp.org/about/Pages/Vitalstats.aspx2010;
  4. Zolezzi M, Blake A. Principles-based learning design for an online postgraduate psychiatric pharmacy course. Am J Pharm Educ. 2008;72:Article 107
  5. Cohen PS. Being “reasonable.” Defining and implementing a right to community-based care for older adults with mental disabilities under the Americans with Disabilities Act. Int J Law Psychiatry. 2001;24:233–252
  6. Lauderdale SA, Kendrach MG, Freeman MK. Preparing students for community pharmacy practice during a drug information advanced practice experience. Am J Pharm Educ. 2007;71:Article 25
  7. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed.. Washington, DC: American Psychiatric Association; 2000;Text Revision
  8. Sockalingam S, Shammi C, Remington G. Clozapine-induced hypersalivation: a review of treatment strategies. Can J Psychiatry. 2007;52:377–384
  9. Dobbs RL, Brahm NC, Fast G, Brown RC. Thyroid function alterations following quetiapine initiation in a developmentally disabled adolescent. Ann Pharmacother. 2004;38:1541–1542
  10. Stevens DL, Lee MR, Padua Y. Olanzapine-associated neuroleptic malignant syndrome in a patient receiving concomitant rivastigmine therapy. Pharmacotherapy. 2008;28:403–405
  11. McBrien JA. Assessment and diagnosis of depression in people with intellectual disability. J Intellect Disabil Res. 2003;47:1–13
  12. Barnes TR. A rating scale for drug-induced akathisia. Br J Psychiatry. 1989;154:672–676

PII: S1877-1297(10)00055-9

doi: 10.1016/j.cptl.2010.04.008

Currents in Pharmacy Teaching and Learning
Volume 2, Issue 3 , Pages 138-143 , July 2010

Article Tools